SI0956010T1 - Pharmaceutical microspheres of valproic acid for oral administration - Google Patents

Pharmaceutical microspheres of valproic acid for oral administration

Info

Publication number
SI0956010T1
SI0956010T1 SI9730352T SI9730352T SI0956010T1 SI 0956010 T1 SI0956010 T1 SI 0956010T1 SI 9730352 T SI9730352 T SI 9730352T SI 9730352 T SI9730352 T SI 9730352T SI 0956010 T1 SI0956010 T1 SI 0956010T1
Authority
SI
Slovenia
Prior art keywords
oral administration
valproic acid
pharmaceutical microspheres
microspheres
pharmaceutical
Prior art date
Application number
SI9730352T
Other languages
English (en)
Slovenian (sl)
Inventor
Christian Langlois
Jean-Yves Lanne
Original Assignee
Sanofi-Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Synthelabo filed Critical Sanofi-Synthelabo
Publication of SI0956010T1 publication Critical patent/SI0956010T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SI9730352T 1996-10-07 1997-10-03 Pharmaceutical microspheres of valproic acid for oral administration SI0956010T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9612201A FR2754177B1 (fr) 1996-10-07 1996-10-07 Microspheres pharmaceutiques d'acide valproique pour administration orale
PCT/FR1997/001762 WO1998015268A1 (fr) 1996-10-07 1997-10-03 Microspheres pharmaceutiques d'acide valproique pour administration orale
EP97943943A EP0956010B1 (fr) 1996-10-07 1997-10-03 Microspheres pharmaceutiques d'acide valproique pour administration orale

Publications (1)

Publication Number Publication Date
SI0956010T1 true SI0956010T1 (en) 2002-10-31

Family

ID=9496427

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9730352T SI0956010T1 (en) 1996-10-07 1997-10-03 Pharmaceutical microspheres of valproic acid for oral administration

Country Status (40)

Country Link
US (3) US20020001598A1 (et)
EP (1) EP0956010B1 (et)
JP (1) JP3523270B2 (et)
KR (1) KR100334687B1 (et)
CN (1) CN100367945C (et)
AR (1) AR013613A1 (et)
AT (1) ATE216228T1 (et)
AU (1) AU731235B2 (et)
BR (1) BR9712268A (et)
CA (1) CA2267096C (et)
CO (1) CO4900080A1 (et)
CZ (1) CZ288876B6 (et)
DE (1) DE69712100T2 (et)
DK (1) DK0956010T3 (et)
DZ (1) DZ2316A1 (et)
EE (1) EE03744B1 (et)
EG (1) EG24070A (et)
ES (1) ES2174293T3 (et)
FR (1) FR2754177B1 (et)
HK (1) HK1021939A1 (et)
HR (1) HRP970537B1 (et)
HU (1) HU225103B1 (et)
ID (1) ID24596A (et)
IL (1) IL128745A (et)
IS (1) IS1985B (et)
ME (1) ME00664B (et)
MY (1) MY120521A (et)
NO (1) NO325723B1 (et)
NZ (1) NZ334399A (et)
PL (1) PL190105B1 (et)
PT (1) PT956010E (et)
RS (1) RS49602B (et)
RU (1) RU2177315C2 (et)
SI (1) SI0956010T1 (et)
SK (1) SK282113B6 (et)
TR (1) TR199900789T2 (et)
TW (1) TW508251B (et)
UY (1) UY24738A1 (et)
WO (1) WO1998015268A1 (et)
ZA (1) ZA978954B (et)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU86001A (sh) 1999-06-07 2004-07-15 Altana Pharma Ag. Novi preparat i oblik, u kojem se daje lek, koji sadrži aktivno jedinjenje labilno prema kiselini
AU2003289782A1 (en) * 2002-12-16 2004-07-09 The University Of British Columbia Valproic acid analogues and pharmaceutical compositions thereof
TWI547431B (zh) * 2004-06-09 2016-09-01 史密斯克萊美占公司 生產藥物之裝置及方法
MX2007002682A (es) * 2004-09-07 2008-03-05 Orphan Medical Inc Composiciones mejoradas de gamma-hidroxibutirato ghb.
US9149433B2 (en) * 2004-11-30 2015-10-06 Basf Corporation Method for formation of micro-prilled polymers
US20060252831A1 (en) * 2005-05-06 2006-11-09 Christopher Offen Method for the treatment of magnesium and potassium deficiencies
US20060252830A1 (en) * 2005-05-06 2006-11-09 Brandon Stephen F Method for the treatment of magnesium and potassium deficiencies
US8992422B2 (en) 2006-03-23 2015-03-31 Ethicon Endo-Surgery, Inc. Robotically-controlled endoscopic accessory channel
CN101543631B (zh) * 2008-03-28 2012-01-11 沈阳兴齐制药有限公司 含蜂蜡的微球基质、含有它的药物组合物及其用途
JP5866279B2 (ja) * 2009-05-12 2016-02-17 株式会社アモーレパシフィックＡｍｏｒｅｐａｃｉｆｉｃ Ｃｏｒｐｏｒａｔｉｏｎ 脱毛防止又は育毛促進のための組成物
CN105899197A (zh) * 2013-11-13 2016-08-24 蒂洛特斯制药股份有限公司 多颗粒药物递送系统
CN104013596A (zh) * 2014-05-16 2014-09-03 安士制药（中山）有限公司 一种丙戊酸软胶囊及其制备方法
CN105456217A (zh) * 2014-08-27 2016-04-06 捷思英达医药技术（上海）有限公司 一种双丙戊酸钠缓释剂组合物及其制备方法
WO2019039345A1 (ja) 2017-08-24 2019-02-28 三井化学株式会社 リチウム二次電池及び非水電解液
JPWO2019039346A1 (ja) 2017-08-24 2020-03-26 三井化学株式会社 電池用非水電解液及びリチウム二次電池
FR3087445B1 (fr) * 2018-10-19 2021-12-17 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Composition lipidique pour l'encapsulation d'une substance active et permettant le controle de la vitesse de liberation de ladite substance active
CN111012753A (zh) * 2020-01-07 2020-04-17 仁和堂药业有限公司 一种提高丙戊酸钠片剂稳定性的方法
CN112274499A (zh) * 2020-11-16 2021-01-29 仁和堂药业有限公司 一种提高丙戊酸钠片剂稳定性的方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2293974A1 (fr) * 1973-03-02 1976-07-09 Kaltenbach Roger Procede et dispositif pour la granulation reguliere de divers produits
US5212326A (en) * 1979-08-20 1993-05-18 Abbott Laboratories Sodium hydrogen divalproate oligomer
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US5185159A (en) * 1983-07-20 1993-02-09 Sanofi Pharmaceutical composition based on valproic acid and a process for preparing it
IL72381A (en) * 1983-07-20 1988-03-31 Sanofi Sa Pharmaceutical composition based on valproic acid
US4913906B1 (en) * 1985-02-28 2000-06-06 Yissum Res Dev Co Controlled release dosage form of valproic acid
JP2893191B2 (ja) * 1988-11-08 1999-05-17 武田薬品工業株式会社 放出制御性マトリックス剤
EP0418596A3 (en) * 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
FR2657257B1 (fr) * 1990-01-19 1994-09-02 Rhone Poulenc Sante Procede de preparation de medicaments sous forme de perles.
TW209174B (et) * 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
ATE120089T1 (de) * 1991-05-20 1995-04-15 Marion Laboratories Inc Mehrschichtige zubereitung mit kontrollierter freisetzung.
FR2682677A1 (fr) * 1991-10-17 1993-04-23 Sanofi Elf Complexe forme de l'acide propyl-2 pentene-2 ouique (e) et de son sel de sodium, sa preparation et compositions pharmaceutiques le contenant.
US6287598B1 (en) * 1993-05-28 2001-09-11 Alza Corporation Method for providing sustained antiepileptic therapy
US5690959A (en) * 1993-05-29 1997-11-25 Smithkline Beecham Corporation Pharmaceutical thermal infusion process
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
US5916910A (en) * 1997-06-04 1999-06-29 Medinox, Inc. Conjugates of dithiocarbamates with pharmacologically active agents and uses therefore
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
UA80393C2 (uk) * 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці

Also Published As

Publication number Publication date
RU2177315C2 (ru) 2001-12-27
IS1985B (is) 2005-02-15
HUP9903855A3 (en) 2000-06-28
FR2754177A1 (fr) 1998-04-10
HK1021939A1 (en) 2000-07-21
PL190105B1 (pl) 2005-10-31
DE69712100D1 (de) 2002-05-23
PT956010E (pt) 2002-08-30
HU225103B1 (en) 2006-06-28
EE03744B1 (et) 2002-06-17
KR100334687B1 (ko) 2002-04-27
ES2174293T3 (es) 2002-11-01
ID24596A (id) 2000-07-27
FR2754177B1 (fr) 1999-08-06
CN100367945C (zh) 2008-02-13
CO4900080A1 (es) 2000-03-27
DZ2316A1 (fr) 2002-12-28
US20060263437A1 (en) 2006-11-23
CN1232391A (zh) 1999-10-20
MY120521A (en) 2005-11-30
AU4560297A (en) 1998-05-05
IS4996A (is) 1999-03-11
CA2267096C (fr) 2003-09-16
SK282113B6 (sk) 2001-11-06
ZA978954B (en) 1999-04-07
JP2000504038A (ja) 2000-04-04
US20030157177A1 (en) 2003-08-21
KR20000048828A (ko) 2000-07-25
TW508251B (en) 2002-11-01
CA2267096A1 (fr) 1998-04-16
CZ288876B6 (cs) 2001-09-12
NO991613D0 (no) 1999-04-06
EP0956010B1 (fr) 2002-04-17
AU731235B2 (en) 2001-03-29
ME00664B (me) 2007-06-04
US8535721B2 (en) 2013-09-17
TR199900789T2 (xx) 1999-07-21
CZ121199A3 (cs) 1999-08-11
DK0956010T3 (da) 2002-08-12
HRP970537B1 (en) 2002-08-31
EE9900140A (et) 1999-12-15
PL332249A1 (en) 1999-08-30
ATE216228T1 (de) 2002-05-15
DE69712100T2 (de) 2002-11-28
AR013613A1 (es) 2001-01-10
EP0956010A1 (fr) 1999-11-17
NO991613L (no) 1999-04-06
SK36499A3 (en) 2000-12-11
JP3523270B2 (ja) 2004-04-26
IL128745A (en) 2004-05-12
US20020001598A1 (en) 2002-01-03
UY24738A1 (es) 2001-05-31
NZ334399A (en) 2000-05-26
HRP970537A2 (en) 1998-08-31
IL128745A0 (en) 2000-01-31
EG24070A (en) 2008-05-11
HUP9903855A2 (hu) 2000-05-28
BR9712268A (pt) 1999-08-31
WO1998015268A1 (fr) 1998-04-16
RS49602B (sr) 2007-06-04
NO325723B1 (no) 2008-07-07
YU17899A (sh) 2000-03-21

Similar Documents

Publication Publication Date Title
IL118637A (en) Oral pharmaceutical compositions of s(+)-ibuprofen
HUP9903855A3 (en) Pharmaceutical microspheres of valproic acid for oral administration
IL116673A (en) Stable oral pharmaceutical composition containing an acid labile benzimidazole
IL128600A0 (en) Propionic acid derivatives and pharmaceutical compositions containing them
IL117265A0 (en) Benzazepine- benzoxazepine- and benzothiazepine-n-acetic acid derivatives their preparation and pharmaceutical compositions containing them
IL115097A0 (en) Pharmaceutical compositions adapted for oral administration
HU9502520D0 (en) Pharmaceutical use of substituted 4-phenyl-6-amino-nicotinic acid derivatives
HUP0000664A3 (en) Azinyloxy, and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use of them for producing pharmaceutical compositions
HUP0001084A3 (en) Modified release oral pharmaceutical composition containing 5-asa for the treatment of bowel diseases
IL118162A0 (en) Nanoparticles for oral administration of pharmaceutical agents of low solubility
IL116480A0 (en) Acetic acid deriratives their preparation and pharmaceutical compositions containing them
IL115125A0 (en) Pharmaceutical formulations comprising derivatives of clavulanic acid
AU1354495A (en) Formulations for orally administered pharmaceutical agents
EP0953359A4 (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
IL127691A0 (en) Useful formulations of acid addition salt drugs
HUP9904320A3 (en) Pharmaceutical compositions of weak acid drugs for colonic delivery
AU5560694A (en) Pharmaceutical formulations of ibuprofen
PL328170A1 (en) Ester-type derivatives of transapovincaminic acid as drugs
AU3860797A (en) Pharmaceutical formulations for oral administration
GB9817348D0 (en) Pharmaceutical use of esters
AU3416895A (en) Compositions and methods for the administration of delta-aminolevulinic acid and pharmaceutical equivalents thereof
ZA913511B (en) New pharmaceutical use of benzocycloheptathiophene carboxylic acid derivatives
AU3570195A (en) Pharmaceutical composition of fantofarone for oral administration
HUP9903695A3 (en) Oxazolyl- and pyridylethoxyphenyl propionic acid derivatives and pharmaceutical compositions containing them
GB9418029D0 (en) Pharmaceutical compositions for oral administration